Hereditary thrombophilia in ethnic Omani patients

American Journal of Hematology

Volumn 81, Issue 2, 2006, Pages 101-106

  Pathare, Anil ^a,b   Al Kindi, Salam ^a   Al Haddabi, Hamood ^a   Dennison, David ^a   Bayoumi, Riad ^a   Muralitharan, S ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

DVT; MTHFR; PE; Thrombophilia; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; D DIMER; GENOMIC DNA; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; INFECTION; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MUTATIONAL ANALYSIS; OMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SCHOOL CHILD; SICKLE CELL ANEMIA; STATISTICAL ANALYSIS; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION DISORDERS, INHERITED; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OMAN; PULMONARY EMBOLISM; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOSIS;

EID: 32144432660     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20525     Document Type: Article

References (30)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-815.
2. Murin S, Marelich GP, Arroliga AC, Matthay RA. Hereditary thrombophilia and venous thromboembolism. Am J Resp Crit Care Med 1998;158:1369-1373.
3. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, and Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-593.
4. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb Vasc Biol 1994;14:1080-1083.
5. Alhenc-Gelas M, Arnaud E, Nicaud V, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999;81:506-510.
6. Sanson BJ, Simioni P, Tormene D, et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999;94:3702-3706.
7. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylene tetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res 1999;93:1-8.
8. Brown K, Luddington R, Baglin T. Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations. Br J Haematol 1998;103:42-44.
9. Lensing AWA, Prandoni P, Prins MH, Buller HR. Deep vein thrombosis. Lancet 1999;353:479-485.
10. de Franchis R, Fermi I, Mazzola G, et al. Contribution of the cystathionine beta synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and fasting hyperhomocysteinemia. Thromb Haemost 2000;84:576-582.
11. rd edition. Philadelphia: Lippincott Williams & Wilkins; 2003. p 363-423.
12. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
13. Frosst P, Blom HJ, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
14. Sebastio G, Sperndeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995;56:1324-1333.
15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
16. Tsai AW, Cushman, Tsai MY, et al. FERUM homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: longitudinal investigation of thromboembolism etiology (LITE). Am J Hematol 2003;72:192-200.
17. Ruiz-Arguelles GR, Lopez-Martinez B, Valdes-Tapia P, Gomez-Rangel JD, Nunez-Reyes V, Gares-Eisele J. Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol 2005;78:21-26.
18. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part 1. Thromb Haemost 1996;76:651-662.
19. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part 2. Thromb Haemost 1996;76:824-834.
20. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G202210A prothrombin mutation. N Engl J Med 1999;341:801-806.
21. Kamphuisen PW, Rosendaal FR. Thrombophilia screening: a matter of debate. Neth J Med 2004;62:180-187.
22. Lopez JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology (Am Soc Hematol Educ Program) 2004;439-456.
23. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536-545.
24. Deloughery TG, Evans A, Sadeghi A, et al. Common mutation on methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late onset vascular disease. Circulation 1996;94:3074-3078.
25. Rosen E, Renbaum P, Heyd J, Levy-Lahad E. High frequency of Factor V Leiden in a population of Israeli Arabs. Thromb Haemost 1999;82:1768.
26. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;34:759-762.
27. Fermo L, Viagano D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995;123:747-753.
28. Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vasc Biol 1995;15:1321-1323.
29. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999;81:165-176.
30. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231.